Form 10-Q - Quarterly report [Sections 13 or 15(d)]

DHCAU DHC Acquisition Corporation

Hot Features

Actualités DHC Acquisition Corporation

Follow Feed

Flux des Options

Moniteur

Dernières Valeurs Consultées

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Société

Entreprise

Popular

Obtenir l'application

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period June 30, 2023

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission file

number: 001-40130

DHC ACQUISITION CORP.

(Exact Name of Registrant as Specified in Its Charter)


Cayman Islands		98-1574798
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

535 Silicon Drive, Suite 100

Southlake, Texas 76092

(Address of principal executive offices)

(214)

452-2300

(Issuer’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A ordinary shares, $0.0001 par value, and one-third of one redeemable warrant	DHCAU	The Nasdaq Stock Market LLC
Class A ordinary shares included as part of the units	DHCA	The Nasdaq Stock Market LLC
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	DHCAW	The Nasdaq Stock Market LLC

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12

b-2 of the Exchange

Act.

If an emerging growth company, indicate by check mark if the

registrant

has elected not to

use

the extended transition period

for

complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of

the

Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act). Yes ☒ No ☐

As of August 14, 2023, there were 4,646,574 Class A ordinary shares, $0.0001 par value and 7,736,268 Class B ordinary shares, $0.0001 par value, issued and outstanding.

DHC ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2023

TABLE OF CONTENTS


	Page
Part I. Financial Information
Item 1. Interim Financial Statements
Condensed Consolidated Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022		1
Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2023 and 2022		2
Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Deficit for the Three and Six Months Ended June 30, 2023 and 2022		3
Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months ended June 30, 2023 and 2022		4
Notes to Unaudited Condensed Consolidated Financial Statements		5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		20
Item 3. Quantitative and Qualitative Disclosures About Market Risk		23
Item 4. Controls and Procedures		23
Part II. Other Information
Item 1. Legal Proceedings		24
Item 1A. Risk Factors		24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		24
Item 3. Defaults Upon Senior Securities		24
Item 4. Mine Safety Disclosures		24
Item 5. Other Information		24
Item 6. Exhibits		25
Part III. Signatures		26

PART I—FINANCIAL INFORMATION

Item 1.

Interim

Financial Statements.

DHC ACQUISITION CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS


	June 30, 2023			December 31, 2022
	(Unaudited)
ASSETS
Current assets
Cash	$	30,294		$	212,608
Due from Sponsor		3,000			1,500
Prepaid expenses and other assets		43,629			61,530

Total Current Assets		76,923			275,638
Trust Account receivable		32,565			—
Cash and investments held in Trust Account		48,590,022			313,913,217

TOTAL ASSETS	$	48,699,510		$	314,188,855

LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT
Current liabilities
Accounts payable and accrued expenses	$	5,803,741		$	5,440,933
Related party advances		300,000			—

Total Current Liabilities		6,103,741			5,440,933
Warrant liabilities		776,017			164,410
Deferred underwriting fee payable		10,830,775			10,830,775

Total Liabilities		17,710,533			16,436,118

Commitments and Contingencies
Class A ordinary shares subject to possible redemption; 4,646,574 and 30,945,072 shares at a redemption value of $ 10.46 and $ 10.14 per share at June 30, 2023 and December 31, 2022, respectively		48,622,587			313,913,217

Shareholders’ Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding		—			—
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding (excluding 4,646,574 and 30,945,072 shares subject to possible redemption at June 30, 2023 and December 31, 2022)		—			—
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,736,268 shares issued and outstanding at June 30, 2023 and December 31, 2022		774			774
Additional paid-in capital		—			—
Accumulated deficit		(17,634,384	)		(16,161,254	)

Total Shareholders’ Deficit		(17,633,610	)		(16,160,480	)

TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT	$	48,699,510		$	314,188,855

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

DHC ACQUISITION CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2023			2022			2023			2022
Operating and formation costs	$	547,114		$	243,574		$	861,523		$	1,946,336

Loss from operations		(547,114	)		(243,574	)		(861,523	)		(1,946,336	)
Other income (expenses):
Change in fair value of warrant liabilities		(228,531	)		2,594,396			(611,607	)		7,097,595
Interest earned on cash and investments held in the Trust Account		519,310			417,862			3,294,864			448,071

Other income, net		290,779			3,012,258			2,683,257			7,545,666

Net income (loss)	$	(256,335	)	$	2,768,684		$	1,821,734		$	5,599,330

Weighted average shares outstanding of Class A ordinary shares		4,646,574			30,945,072			15,458,179			30,945,072

Basic and diluted net income (loss) per share, Class A ordinary shares	$	(0.02	)	$	0.07		$	0.08		$	0.14

Weighted average shares outstanding of Class B ordinary shares		7,736,268			7,736,268			7,736,268			7,736,268

Basic and diluted net income (loss) per share, Class B ordinary shares	$	(0.02	)	$	0.07		$	0.08		$	0.14

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

DHC ACQUISITION CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023


	Class B Ordinary Shares				Additional Paid-in Capital			Accumulated Deficit			Total Shareholders’ Deficit
	Shares		Amount		Additional Paid-in Capital			Accumulated Deficit			Total Shareholders’ Deficit
Balance — January 1, 2023		7,736,268	$	774	$	—		$	(16,161,254	)	$	(16,160,480	)
Shareholder non redemption agreement		—		—		(744,274	)		—			(744,274	)
Contribution by Sponsor		—		—		744,274			—			744,274
Accretion for Class A ordinary shares to redemption amount		—		—		—			(2,775,554	)		(2,775,554	)
Net income		—		—		—			2,078,069			2,078,069

Balance — March 31, 2023 (unaudited)		7,736,268		774		—			(16,858,739	)		(16,857,965	)
Accretion for Class A ordinary shares to redemption amount		—		—		—			(519,310	)		(519,310	)
Net loss		—		—		—			(256,335	)		(256,335	)

Balance — June 30, 2023 (unaudited)		7,736,268	$	774	$	—		$	(17,634,384	)	$	(17,633,610	)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022


	Class B Ordinary Shares				Additional Paid-in Capital		Accumulated Deficit			Total Shareholders’ Deficit
	Shares		Amount		Additional Paid-in Capital		Accumulated Deficit			Total Shareholders’ Deficit
Balance — January 1, 2022		7,736,268	$	774	$	—	$	(18,905,470	)	$	(18,904,696	)
Net income		—		—		—		2,830,646			2,830,646

Balance — March 31, 2022 (unaudited)		7,736,268		774		—		(16,074,824	)		(16,074,050	)
Accretion for Class A ordinary shares to redemption amount		—		—		—		(448,071	)		(448,071	)
Net income		—		—		—		2,768,684			2,768,684

Balance — June 30, 2022 (unaudited)		7,736,268	$	774	$	—	$	(13,754,211	)	$	(13,753,437	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

DHC ACQUISITION CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


	For the Six Months Ended June 30,
	2023			2022
Cash Flows from Operating Activities:
Net income	$	1,821,734		$	5,599,330
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on cash and investments held in Trust Account		(3,294,864	)		(448,071	)
Change in fair value of warrant liabilities		611,607			(7,097,595	)
Changes in operating assets and liabilities:
Due from Sponsor		(1,500	)		(1,500	)
Prepaid expenses		17,901			119,464
Accounts payable and accrued expenses		362,808			1,372,543

Net cash used in operating activities		(482,314	)		(455,829	)

Cash Flows from Investing Activities:
Cash withdrawn from Trust Account in connection with redemption		268,585,494			—

Net cash provided by investing activities		268,585,494			—

Cash Flows from Financing Activities:
Related party advance		300,000			—
Redemption of ordinary shares		(268,585,494	)		—

Net cash used in financing activities		(268,285,494	)		—

Net Change in Cash		(182,314	)		(455,829	)
Cash – Beginning of the period		212,608			861,474

Cash – End of the period	$	30,294		$	405,645

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

DHC Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on

December 22, 2020

. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company has one wholly owned subsidiary that were created on

July 22, 2022

, Glory Merger Subsidiary Corp., a Delaware corporation (“Merger Sub”).

The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

On March 3, 2023, the Company held an extraordinary general meeting (the “Extension Meeting”) to vote on a number of proposals, including a proposal to approve an amendment the Company’s amended and restated memorandum and articles of association to (i) extend the date by which the Company has to consummate a business combination from March 4, 2023 to December 4, 2023 (the “Combination Period”). The proposal was approved by the Company’s shareholders. In connection with the Extension Meeting, the holders of 26,298,498 Class A ordinary shares of the Company (the “Redeeming Shareholders”) properly exercised their right to redeem their Class A ordinary shares for cash at a redemption price of approximately $10.21 per share, for an aggregate redemption amount of approximately $268,585,000. This could adversely impact the Company’s ability to consummate a business combination within the Combination Period.

All activity through June 30, 2023 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates

non-operating

income in the form of interest income

from the cash held in an interest bearing account), along

with income or loss from the change in fair value of the warrant liabilities.

The registration statement for the Company’s Initial Public Offering was declared effective on March 1, 2021. On March 4, 2021, the Company consummated the Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300,000,000 which is described in Note 3.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,000,000 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor generating gross proceeds of $9,000,000, which is described in Note 4.

Following the closing of the Initial Public Offering on March 4, 2021, an amount of $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of

Rule2a-7of

the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.

On March 5, 2021, the underwriters partially exercised their over-allotment option, resulting in an additional 945,072 Units issued for an aggregate amount of $9,450,720. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 126,010 Private Placement Warrants at $1.50 per Private Placement Warrant, generating total proceeds of $189,015. A total of $9,450,720 was deposited into the Trust Account, bringing the aggregate proceeds deposited in the Trust Account to $309,450,720.

Transaction costs amounted to $17,501,346, consisting of $6,189,014 in cash underwriting fees, net of reimbursement, $10,830,775 of deferred underwriting fees and $481,557 of other offering costs.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The rules of the stock exchange that the Company will list its securities on will require that the Company’s initial Business Combination must be with one or more target businesses that have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the signing of a definitive agreement in connection with the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30,

2023

The Company will provide the holders of its issued and outstanding Public Shares (the “Public

Shareholders

”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and net of taxes payable), divided by the number of then issued and outstanding Public Shares. The

per-share

amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote any Founder Shares (as defined in Note 5) and Public Shares held by it in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against an Initial Business Combination.

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association will provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.

The Sponsor and the Company’s officers and directors have agreed to waive (i) their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with the completion of the Company’s Business Combination and (ii) their redemption rights with respect to the Founder Shares and any Public Shares held by them in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period or (B) with respect to any other provision relating to shareholders’ rights and (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to consummate an initial business combination within the Combination Period.

If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at aper-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30,

2023

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the

Sponsor

acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the

per-share

value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

On July 25, 2022, we entered into a Business Combination Agreement and Plan of Reorganization (the “Business Combination Agreement”), by and among the Company, Glory Merger Subsidiary Corp., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”) and With Purpose, Inc. (d/b/a GloriFi, Inc.) a Delaware corporation (“GloriFi”). On January 26, 2023, we sent GloriFi written notice that we had terminated the Business Combination Agreement, pursuant to Section 9.01(i) and Section 9.01(f) the Business Combination Agreement. Our decision to terminate the Business Combination Agreement took into account the fact that GloriFi had previously publicly announced that GloriFi was winding down its operations and closing its digital banking platform and other products. As a result of the termination of the Business Combination Agreement, each of the Ancillary Agreements (as defined in the Business Combination Agreement) were terminated.

Liquidity and Going Concern

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As of June 30, 2023, the Company had $30,294 in its operating bank account and a working capital deficit of $6,026,818.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of June 30, 2023, there were no amounts outstanding under any Working Capital Loan.

In connection with the extraordinary general meeting of shareholders held on March 3, 2023 (the “Extension Meeting”), to extend the date by which the Company has to consummate a business combination (the “Articles Extension”) from March 4, 2023 to December 4, 2023, the Company and the Sponsor, have entered into one or more

non-redemption

agreements (the

“Non-Redemption

Agreements”), with several unaffiliated third parties, pursuant to which such third parties agreed not to redeem (or to validly rescind any redemption requests on) an aggregate of 400,000 previously-held Class A ordinary shares of the

Company (“Non-Redeemed

Shares”) in connection with the Articles Extension. In exchange for the foregoing commitments not to redeem such previously held Class A ordinary shares, the Sponsor agreed to transfer an aggregate of 150,000 Class B ordinary shares of the Company held by the Sponsor to such third parties immediately following consummation of an initial business combination if such third parties continued to hold such

Non-Redeemed

Shares through the Extension Meeting. In Connection with Extension meeting, the Redeeming Shareholders properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.21 per share, for an aggregate redemption amount of approximately $268,585,000.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30,

2023

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”)

2014-15,

“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 4, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management plans to consummate a business combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 4,

2023

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form

10-Q

and Article 8 of Regulation

S-X

of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report

on Form

10-K

as filed with

the SEC on March 30, 2023. The interim results for the three and six months ended June 30, 2023, are not necessarily indicative of the results to be expected for the year ending December 31, 2023, or for any future periods.

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, which was formed on July 22, 2022. All significant intercompany balances and transactions have been eliminated in consolidation.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL

STATEMENTS

JUNE 30, 2023

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to

one or more future confirming events

. One of the more significant accounting estimates included in these unaudited condensed consolidated financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of

three months

or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.

Cash and Investments Held in Trust Account

At June 30, 2023, assets held in the Trust Account were comprised of $48,590,022 in cash. At December 31, 2022, assets held in the Trust Account were comprised of $313,913,217 invested primarily in U.S. Treasury Securities. In order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company working capital loans, as defined below.

Trust Account Receivable

In connection with the Extension Meeting, as described in Note 1, due to a clerical error by the trustee of the Trust Account, the Redeeming Shareholders were overpaid approximately $0.03 per Class A ordinary share that was redeemed, for an aggregate total overpayment amount of $887,555 (the “Overpayment Amount”). As of June 30, 2023, the Company has collected $854,990 of the overpayment and $32,565 remains receivable. The Company is in process of collecting the remaining Overpayment Amount and currently expects to fully recover the total Overpayment Amount.

Concentration of Credit Risk

The Company has historically had significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

Offering Costs

Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as incurred in the unaudited condensed consolidated statements of operations. Offering costs associated with the Class A ordinary shares issued were initially charged to temporary equity and then accreted to the redemption value of the Class A ordinary shares subject to redemption upon the completion of the Initial Public Offering. Offering costs amounted to $

17,501,346

, of which $

16,915,008

was charged to temporary shareholders’ deficit upon the completion of the Initial Public Offering and $

586,339

was expensed at the date of the initial public offering.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption, if any, are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2023 and December 31, 2022, 4,646,574 and 30,945,072 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed consolidated balance sheets, respectively.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional

paid-in

capital and accumulated deficit.

At June 30, 2023 and December 31, 2022, the Class A ordinary shares reflected in the unaudited condensed consolidated balance sheets are reconciled in the following table:


Gross proceeds	$	309,450,720
Less:
Proceeds allocated to Public Warrants		(10,211,874	)
Class A ordinary shares issuance costs		(16,924,264	)
Plus:
Accretion of carrying value to redemption value		27,136,138

Class A ordinary shares subject to possible redemption as of December 31, 2021		309,450,720
Plus:
Accretion of carrying value to redemption value		4,462,497

Class A ordinary shares subject to possible redemption as of December 31, 2022		313,913,217
Less:
Redemption		(268,585,494	)
Plus:
Accretion of carrying value to redemption value		3,294,864

Class A ordinary shares subject to possible redemption as of June 30, 2023 (unaudited)	$	48,622,587

Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company accounts for the Warrants in accordance with the guidance contained in

ASC815-40

under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to

re-measurement

at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed consolidated statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to

the

detachment of the Public Warrants from the Units, the Public Warrant quoted market price will be used as the fair value as of each relevant date.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

Income Taxes

The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2023 and December 31, 2022, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

Net Income (Loss) per Ordinary Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net Income (Loss) per ordinary share is computed by dividing net Income (Loss) by the weighted average number of ordinary shares outstanding for the period. The Company applies the

two-class

method in calculating Income (Loss) per ordinary share. Accretion associated with the redeemable shares of Class A ordinary share is excluded from Income (Loss) per ordinary share as the redemption value approximates fair value.

The calculation of diluted Income (Loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase

16,441,034

shares of Class A ordinary share in the aggregate. As of June 30, 2023 and 2022, the Company did

have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net Income (Loss) per ordinary share is the same as basic net Income (Loss) per ordinary share for the periods presented.

The following table reflects the calculation of basic and diluted net Income (Loss) per ordinary share (in dollars, except per share amounts):


	For the Three Months Ended June 30,
	2023						2022
	Class A			Class B			Class A		Class B
Basic and diluted net Income (Loss) per ordinary share
Numerator:
Allocation of net Income (Loss), as adjusted	$	(96,188	)	$	(160,147	)	$	2,214,947	$	553,737
Denominator:
Basic and diluted weighted average shares outstanding		4,646,574			7,736,268			30,945,072		7,736,268

Basic and diluted net Income (Loss) per ordinary share	$	(0.02	)	$	(0.02	)	$	0.07	$	0.07


	For the Six Months Ended June 30,
	2023				2022
	Class A		Class B		Class A		Class B
Basic and diluted net income per ordinary share
Numerator:
Allocation of net income, as adjusted	$	1,214,113	$	607,621	$	4,479,464	$	1,119,866
Denominator:
Basic and diluted weighted average shares outstanding		15,458,179		7,736,268		30,945,072		7,736,268

Basic and diluted net income per ordinary share	$	0.08	$	0.08	$	0.14	$	0.14

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE

, 2023

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximate the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for the warrant liabilities (see Note 9).

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”)

2020-06,

Debt—Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic

815-40)

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all convertible instruments. As a smaller reporting company, ASU

2020-06

is effective January 1, 2024 for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU

2020-06

would have on its financial position, results of operations or cash flows. The Company has not adopted this guidance as of June 30, 2023.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.

NOTE 3. PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 30,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and

one-third

of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9). On March 5, 2021, the underwriters partially exercised their over-allotment option, resulting in an additional 945,072 Units issued for an aggregate amount of $9,450,720. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 126,010 Private Placement Warrants at $1.50 per Private Placement Warrant, generating total proceeds of $189,015. A total of $9,450,720 was deposited into the Trust Account, bringing the aggregate proceeds deposited in the Trust Account to $309,450,720.

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased 6,000,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $9,000,000. The Sponsor agreed to purchase up to an additional 600,000 Private Placement Warrants, for an aggregate purchase price of an additional $900,000, if the over-allotment option is exercised in part by the underwriters. On March 5, the Sponsor purchased 126,010 Private Placement Warrants for an additional aggregate purchase price of $189,015 in connection with the partial exercise of the underwriter’s over-allotment option. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

In December 2020, the Sponsor paid $25,000 to cover certain expenses on behalf of the Company in consideration for 7,187,500 Class B ordinary shares (the “Founder Shares”). On March 1, 2021, the Company effected a share capitalization, pursuant to which an additional 1,437,500 Class B ordinary shares were issued, resulting in an aggregate of 8,625,000 Founder Shares outstanding. Historical information has been retroactively restated. The Founder Shares included an aggregate of up to 1,125,000 shares that were subject to forfeiture by the Sponsor following to the extent the underwriters’ election to exercise their over-allotment option was not exercised so that the number of Founder Shares collectively represented 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). As a result of the underwriters’ not exercising their overallotment option in full, 888,732 Founder Shares were forfeited on March 4, 2021.

The Sponsor has agreed, not to transfer, assign or sell any Founder Shares until the earlier to occur of (i) one year after the completion of the Company’s Business Combination and (ii) subsequent to a Business Combination, (x) if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading day

period commencing at least 150 days after the Company’s Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, or other similar transaction that results in all of the Company’s public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.

Administrative Services Agreement

The Company entered into an agreement, commencing on March 4, 2021, through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, secretarial and administrative services. For the three and six months ended June 30, 2023, the total expense for administrative services was $30,000 and $60,000, respectively. For the three and six months ended June 30, 2022, the total expense for administrative services was $30,000 and $60,000, respectively. As of June 30, 2023 and December 31, 2022, the Company had $60,000 and $120,000 included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheets, respectively.

Promissory Note — Related Party

On December 29, 2020, the Sponsor issued an unsecured promissory

note

to the Company (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was

non-interest

bearing and payable on the earlier of (i) July 31, 2021 or (ii) the completion of the Initial Public Offering. The outstanding amount of $171,357 was repaid after the closing of the Initial Public Offering on March 9, 2021. Borrowings under the Promissory Note are no longer available.

Related Party Advance

On March 3, 2023, the Sponsor advanced the Company $50,000. On April 18, 2023, the Sponsor additionally advanced the Company $250,000. The related party advances are non-interest bearing and payable upon demand. As of June 30, 2023 and December 31, 2022, the Company had $300,000 and $0 included in related party advances in the accompanying condensed

consolidated

balance sheets.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. Such warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of June 30, 2023 and December 31, 2022, there were no working capital loans outstanding.

Non-Redemption

Agreement

On February 28, 2023, the Sponsor entered into

Non-Redemption

Agreements with various stockholders of the

Company

pursuant to which these stockholders have committed not to redeem their Class A Ordinary Shares of the company in connection with the Extension Meeting held on March 3, 2023, but still retained their right to redeem their respective shares in connection with the closing of a Business Combination. The commitment to not redeem was accepted by holders of 400,000 shares of Class A Ordinary Shares. In consideration of this agreement, the Sponsor has agreed to transfer 150,000 of its Class B Ordinary shares to the

Non-Redeeming

Stockholders at the closing of a Business Combination. Each shareholder committed to maintain, and not to redeem at the Extension Meeting, the lesser of (i) 400,000 Class A Ordinary Shares and (ii) 9.9% of the Company’s Class A Ordinary Shares. The Company estimated the aggregate fair value of the 150,000 founders shares attributable to the

Non-Redeeming

Shareholders to be $744,274 or $4.96 per share. Each

Non-Redeeming

Shareholder acquired from the Sponsor an indirect economic interest in the founder shares. The excess of the fair value of the founder shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, in substance, it was recognized by the Company as a capital contribution by the Sponsor to induce these holders of the Class A Ordinary Shares not to redeem, with a corresponding charge to additional

paid-in

capital to recognize the fair value of the shares transferred as an offering cost during the three and six months ended June 30, 2023.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

The fair value of the founders shares was based on the following significant inputs:


	February 28, 2023
Risk-free interest rate		4.72	%
Remaining life of SPAC		0.68
Value in no De-SPAC scenario	$	0.00
Probability of transaction		50.00	%

NOTE 6. COMMITMENTS AND CONTINGENCIES

Risks and Uncertainties

Management continues to evaluate the

impact of the COVID-19 pandemic and has concluded

that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or the completion of the Business Combination, the specific impact is not readily determinable as of the date of these unaudited condensed consolidated financial statements. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Various social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide. Specifically, the rising conflict between Russia and Ukraine, and resulting market volatility could adversely affect the Company’s ability to complete a business combination. In response to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a business combination and the value of the Company’s securities.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

Registration Rights

Pursuance to a registration rights agreement entered into on March 4, 2021, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities.

In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provide that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i) in the case of the Founder Shares, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying

such warrants,

days

after the completion of the Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters

45-day

option

from the date of the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On March 5, 2021, the underwriters elected to partially exercise their over-allotment option to purchase an additional 945,072 Units and their option to purchase an additional 3,554,928 Units expired.

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,830,775 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Consulting Agreement

On January 27, 2021, the Company entered into a Consulting Agreement for financial advisory services. The Company agrees to pay the consultant $2,000,000 and reimburse the consultant for all reasonable and documented expenses, which shall be earned upon announcement of an initial Business Combination and payable at the closing of the initial Business Combination.

Business Combination Agreement

On July 25, 2022, the Company entered into the Business Combination Agreement, by and among the Company, Merger Sub and GloriFi which was subsequently terminated on January 26, 2023.

Business Combination Expense Reimbursement Agreement

On February 21, 2022, the Company and GloriFi entered into an agreement pursuant to which GloriFi agreed to reimburse the Company certain business combination related expenses. During the year ended December 31, 2022, the Company wrote off $517,430 as bad debt in relation to this agreement.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

Termination of Business Combination Agreement

On January 26, 2023, the Company sent GloriFi written notice that the Company had terminated the Business Combination Agreement, pursuant to Section 9.01(i) and Section 9.01(f) the Business Combination Agreement. The Company’s decision to terminate the Business Combination Agreement took into account the fact that GloriFi publicly announced that GloriFi was winding down its operations and closing its digital banking platform and other products.

As a result of the termination of the Business Combination Agreement, each of the Ancillary Agreements (as defined in the Business Combination Agreement) were terminated.

NOTE 7. SHAREHOLDERS’ DEFICIT

Preference Shares

—

The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.

Class

A Ordinary Shares

— The Company is authorized to issue 500,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At June 30, 2023 and December 31, 2022, there were 4,646,574 and 30,945,072 shares of Class A ordinary shares subject to possible redemption, respectively, which are presented as temporary equity.

Class

B Ordinary Shares

— The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. At June 30, 2023 and December 31, 2022, there were 7,736,268 shares of Class B ordinary shares issued and outstanding.

Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law; provided that only holders of Class B ordinary shares have the right to vote on the appointment of directors prior to the Company’s initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 20% of the sum of all ordinary shares issued and outstanding upon completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company).

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

NOTE 8. WARRANT LIABILITIES

As of June 30, 2023 and December 31, 2022, there were 10,315,024 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a)

one year

from the closing of the Initial Public Offering and (b) 30 days after the completion of a Business Combination. The Public Warrants will expire

five years

after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

The Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of the Company’s Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Once the warrants become exercisable, the Company may redeem the Public Warrants for redemption (Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00):

•

in whole and not in part;

•

at a price of $

0.01

per warrant;

•

upon a minimum of

days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $

18.00

per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any

trading days within a

trading days period ending three trading days before the Company sends the notice of redemption to the warrant holders.

The Company will not redeem the warrants unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout

the 30-day redemption

period. If and when the warrants become redeemable the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption

of warrants when the price per Class

A ordinary share equals or exceeds $10.00.

Once the warrants become exercisable, the Company may redeem the outstanding warrants:

•

in whole and not in part;

•

at $

0.10

per warrant upon a minimum of

days’ prior written notice of redemption

provided

that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the “fair market value” of the Class A ordinary shares;

•

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $

10.00

per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any

trading days within the

trading day period ending three trading days before the Company send the notice of redemption to the warrant holders; and

•

if the closing price of the Class A ordinary shares for any

trading days within

-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $

18.00

per share, the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants.

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

In addition, if (x) the Company issue additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

As of June 30, 2023 and December 31, 2022, there were 6,126,010 Private Placement Warrants outstanding. The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that (x) the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be

non-redeemable

as described above so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

NOTE 9. FAIR VALUE MEASUREMENTS

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:


Level 1:		Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:		Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:		Unobservable inputs based on an assessment of the assumptions that market participants would use in pricing the asset or liability.

At June 30, 2023, assets held in the Trust Account were comprised of $48,590,022 of cash. During the period ended June 30, 2023, the Company did not withdraw any interest income from the Trust Account.

At December 31, 2022, assets held in the Trust Account were comprised of $313,913,217 of money market funds which are invested primarily in U.S. Treasury Securities. During the year ended December 31, 2022, the Company did not withdraw any interest income from the Trust Account.

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at June 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:


	June 30, 2023				December 31, 2022
	Level		Amount		Level		Amount
Assets:
Cash and investments held in Trust Account		1	$	48,590,022		1	$	313,913,217
Liabilities:
Warrant Liabilities – Public Warrants		2	$	486,869		2	$	103,150
Warrant Liabilities – Private Placement Warrants		2	$	289,148		2	$	61,260

Table of Contents

DHC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

The Warrants were accounted for as liabilities in accordance with ASC

815-40

and are presented within warrant liabilities on the Company’s accompanying June 30, 2023 and December 31, 2022 condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the unaudited condensed consolidated statements of operations.

The Company established the initial fair value for the Warrants on March 4, 2021, the date of the Company’s Initial Public Offering, using a Monte Carlo Simulation for the Private Placement Warrants and the Public Warrants. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units was established by the public warrant price. The subsequent measurements of the Private Placement Warrants was established by using the closing price of the Public Warrants, an observable market quote for a similar asset in an active market. For June 30, 2023 and December 31, 2022, the Public Warrants have detached from the Units, and the closing price is utilized as the fair value.

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. Due to the lack of an active market, the estimated fair value of the Public Warrants transferred from a Level 1 measurement to a Level 2 fair value measurement during year ended December 31, 2022 was $1,031,502.

NOTE 10. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the condensed consolidated balance sheets date up to the date that the unaudited condensed consolidated financial statements were available to be issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to DHC Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to DHC Sponsor, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Such statements include, but are not limited to, possible business combinations, and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Quarterly Report. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the SEC. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in the Cayman Islands on December 22, 2020 formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. We intend to effectuate our business combination using cash derived from the proceeds of the initial public offering and the sale of the private placement warrants, our shares, debt or a combination of cash, shares and debt. On July 25, 2022, we entered into a Business Combination Agreement and Plan of Reorganization (the “Business Combination Agreement”), by and among the Company, Glory Merger Subsidiary Corp., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”) and With Purpose, Inc. (d/b/a GloriFi, Inc.) a Delaware corporation (“GloriFi”). On January 26, 2023, we sent GloriFi written notice that we had terminated the Business Combination Agreement, pursuant to Section 9.01(i) and Section 9.01(f) the Business Combination Agreement. Our decision to terminate the Business Combination Agreement took into account the fact that GloriFi had previously publicly announced that GloriFi was winding down its operations and closing its digital banking platform and other products.

On March 3, 2023, we held an extraordinary general meeting (the “Extension Meeting”) to vote on a number of proposals, including a proposal to approve an amendment to our amended and restated memorandum and articles of association to (i) extend the date by which we have to consummate a business combination from March 4, 2023 to December 4, 2023 (the “Combination Period”). The proposal was approved by our shareholders. In connection with the Extension Meeting, the holders of 26,298,498 Class A ordinary shares of the Company (the “Redeeming Shareholders”) properly exercised their right to redeem their Class A ordinary shares for cash at a redemption price of approximately $10.21 per share, for an aggregate redemption amount of approximately $269,585,000. This could adversely impact our ability to consummate a business combination within the Combination Period.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities through June 30, 2023 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended June 30, 2023, we had a net loss of $256,335, which consists of the operating and formation costs of $547,114 and change in fair value of warrant liabilities of $228,531, offset by interest earned on cash held in the Trust Account of $519,310.

For the three months ended June 30, 2022, we had a net income of $2,768,684, which consists of the change in fair value of warrant liabilities of $2,594,396 and interest earned on cash and investments held in the Trust Account of $417,862, offset by operating and formation costs of $243,574.

For the six months ended June 30, 2023, we had a net income of $1,821,734, which consists of interest earned on cash and investments held in the Trust Account of $3,294,864, offset by the operating and formation costs of $861,523 and change in fair value of warrant liabilities of $611,607.

For the six months ended June 30, 2022, we had a net income of $5,599,330, which consists of the change in fair value of warrant liabilities of $7,097,595 and interest earned on cash and investments held in the Trust Account of $448,071, offset by operating and formation costs of $1,946,336.

Liquidity and Capital Resources

On March 4, 2021, we consummated the Initial Public Offering of 30,000,000 Units at $10.00 per Unit, generating gross proceeds of $300,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 6,000,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $9,000,000.

On March 5, 2021, the underwriters of our initial public offering partially exercised their over-allotment option, and we consummated the sale of an additional 945,072 Units at a price of $10.00 per Unit, generating total gross proceeds of $9,450,720. In addition, we also consummated the sale of an additional 126,010 private placement warrants at $1.50 per private warrant, generating total gross proceeds of $189,015.

Following the Initial Public Offering, the partial exercise of the over-allotment option, and the sale of the private placement warrants, a total of $309,450,720 was placed in the Trust Account. We incurred $17,501,346 in Initial Public Offering related costs, including $6,189,014 of underwriting fees, net of reimbursement, $10,830,775 of deferred underwriting fees and $481,557 of other costs.

For the six months ended June 30, 2023, cash used in operating activities was $482,314. Net income of $1,821,734 was affected by change in fair value of warrant liabilities of $611,607 and interest earned on cash held in the Trust Account of $3,294,864. Changes in operating assets and liabilities provided $379,209 of cash for operating activities.

For the six months ended June 30, 2022, cash used in operating activities was $455,829. Net income of $5,599,330 was affected by change in fair value of warrant liabilities of $7,097,595 and interest earned on cash held in the Trust Account of $448,071. Changes in operating assets and liabilities provided $1,490,507 of cash for operating activities.

As of June 30, 2023, we had cash held in the Trust Account of $48,590,022. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our business combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies. On March 3, 2023, we held the Extension Meeting to, in part, amend our amended and restated memorandum and articles of association to extend the date by which we have to consummate a business combination. In connection with that vote, the Redeeming Shareholders properly exercised their right to redeem their shares for an aggregate redemption amount of approximately $268,585,000. In connection with the extension, the trustee of the Trust Account placed the funds remaining in the Trust Account in an interest bearing cash bank account. The Trust Account does not hold any investments.

As of June 30, 2023, we had cash of $30,294. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we will repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.50 per warrant, at the option of the lender. The warrants would be identical to the Private Placement Warrants.

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASU2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 4, 2023, to consummate a business combination. It is uncertain that the Company will be able to consummate a business combination by this time. If a business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a business combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management plans to consummate a business combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 4, 2023.

Based on the foregoing, management has determined that we do not have sufficient liquidity to meet our anticipated obligations for at least twelve months after the financial statements are available to be issued, as such, the events and circumstances raise substantial doubt about our ability to continue as a going concern, as discussed further below. The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis and do not include any adjustments that might arise as a result of uncertainties about our ability to continue as a going concern.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2023. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of one of our Sponsor a monthly fee of $10,000 for office space, utilities and secretarial and administrative services. We began incurring these fees on March 4, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation.

The underwriters of our initial public offer are entitled to a deferred fee of $0.35 per unit, or $10,830,775 in the aggregate. The deferred fee will become payable to the underwriters of our initial public offering from the amounts held in the Trust Account solely in the event that we complete a business combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies

The preparation of unaudited condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Warrant Liabilities

We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815. We account for the Warrants in accordance with the guidance contained in ASC 815-40 under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, we classify the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our unaudited condensed consolidated statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price will be used as the fair value as of each relevant date.

Class A Ordinary Shares Subject to Possible Redemption

We account for our ordinary shares subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption, if any, are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of our condensed consolidated balance sheets.

Net Income (Loss) Per Ordinary Share

Net income (loss) per ordinary share is computed by dividing net (loss) income by the weighted average number of ordinary shares outstanding during the period. We apply the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

Recent Accounting Pronouncements

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. As a smaller reporting company, ASU 2020-06 is effective January 1, 2024 for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company has not adopted this guidance as of June 30, 2023.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed consolidated financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2023. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective due to its review and approval procedures for the quarterly financial statements.

Management intends to enhance our review and approval procedures for the quarterly financial statements, including through enhanced analyses by our personnel and third-party professionals. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2023 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our Annual Report on Form 10-K for the period ended December 31, 2022, which was filed with the SEC on March 30, 2023 (our “Annual Report”). As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K and our Q1 Quarterly Report filed with the SEC. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. The information presented below updates, and should be read in conjunction with, the risk factors disclosed in our Annual Report and other reports we file with, or furnish to, the SEC. There have been no material changes in our risk factors since such filings.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On March 4, 2021, we consummated the Initial Public Offering of 30,000,000 Units. The Units were sold at an offering price of $10.00 per unit, generating total gross proceeds of $300,000,000. Citigroup Global Markets Inc. acted as sole book-running manager and Drexel Hamilton, LLC and Roberts & Ryan Investments, Inc. acted as co-managers, of the Initial Public Offering. The securities in the offering were registered under the Securities Act on registration statement on FormS-1 (No.333-252891). The SEC declared the registration statements effective on March 1, 2021.

Simultaneous with the consummation of the Initial Public Offering, the Sponsor consummated the private placement of an aggregate of 6,000,000 Warrants at a price of $1.50 per Private Placement Warrant, generating total proceeds of $9,000,000. Each whole Private Warrant is exercisable to purchase one ordinary share at an exercise price of $11.50 per share. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

The Private Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants are not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions.

On March 5, 2021, the underwriters partially exercised their over-allotment option, resulting in the sale of an additional 945,072 Units for gross proceeds of $9,450,720, less the underwriters’ discount of $189,014. In connection with the underwriters’ exercise of their over-allotment option, the Company also consummated the sale of an additional 126,010 Private Placement Warrants at $1.50 per Private Placement Warrant, generating total proceeds of $189,015. A total of $9,450,720 was deposited into the Trust Account.

Of the gross proceeds received from the Initial Public Offering, the exercise of the over-allotment option and the Private Placement Warrants, an aggregate of $309,450,720 was placed in the Trust Account.

We paid a total of $6,189,014 in underwriting discounts and commissions and $481,557 for other costs and expenses related to the Initial Public Offering.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.


No.		Description of Exhibit

3.1		Memorandum and Articles of Association, incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K (File No. 001-40130), filed March 5, 2021

3.2		Amendment to the Amended and Restated Memorandum and Articles of Association, incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K File No. 0001-40130) filed on March 14, 2023

10.1		Form of Non-Redemption Agreements, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K File No. 0001-40130) filed on February 28, 2023

31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1*		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2*		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*		Inline XBRL Instance Document

101.SCH*		Inline XBRL Taxonomy Extension Schema Document

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

*	Filed herewith.

**	Furnished herewith

PART III

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

EXHIBIT 31.1

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Christopher Gaertner, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of DHC Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in exchange act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2023

/s/ Christopher Gaertner

Christopher Gaertner

Co-Chief Executive Officer

(Principal Executive Officer)

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Christopher Gaertner, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of DHC Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2023

/s/ Christopher Gaertner

Christopher Gaertner

Chief Financial Officer

(Principal Financial and Account Officer)

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Christopher Gaertner, Co-Chief Executive Officer of DHC Acquisition Corp. (the “Company”), hereby certifies that, to the best of his knowledge:

1.	The Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2023, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

2.	The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 14, 2023

In Witness Whereof, the undersigned has set his hand hereto as of the 14^th day of August, 2023.

/s/ Christopher Gaertner

Christopher Gaertner

Co-Chief Executive Officer

(Principal Executive Officer)

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Christopher Gaertner, Chief Financial Officer of DHC Acquisition Corp. (the “Company”), hereby certifies that, to the best of his knowledge:

1.	The Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2023, to which this Certification is attached as Exhibit 32.2 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

2.	The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 14, 2023

In Witness Whereof, the undersigned has set his hand hereto as of the 14^thday of August, 2023.

/s/ Christopher Gaertner

Christopher Gaertner

Chief Financial Officer

(Principal Financial and Accounting Officer)

Cover Page - shares	6 Months Ended
Cover Page - shares	Jun. 30, 2023	Aug. 14, 2023
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity Registrant Name	DHC ACQUISITION CORP.
Entity Central Index Key	0001838163
Entity File Number	001-40130
Entity Tax Identification Number	98-1574798
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	E9
Entity Shell Company	true
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, Address Line One	535 Silicon Drive
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Southlake
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	76092
City Area Code	214
Local Phone Number	452-2300
Common Class A [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares included as part of the units
Trading Symbol	DHCA
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		4,646,574
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		7,736,268
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A ordinary shares, $0.0001 par value, and one-third of one redeemable warrant
Trading Symbol	DHCAU
Security Exchange Name	NASDAQ
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	DHCAW
Security Exchange Name	NASDAQ

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 30,294	$ 212,608
Due from Sponsor	3,000	1,500
Prepaid expenses and other assets	43,629	61,530
Total Current Assets	76,923	275,638
Trust Account receivable	32,565	887,555
Cash and investments held in Trust Account	48,590,022	313,913,217
TOTAL ASSETS	48,699,510	314,188,855
Current liabilities
Accounts payable and accrued expenses	5,803,741	5,440,933
Related party advances	300,000
Total Current Liabilities	6,103,741	5,440,933
Warrant liabilities	776,017	164,410
Deferred underwriting fee payable	10,830,775	10,830,775
Total Liabilities	17,710,533	16,436,118
Commitments and Contingencies
Class A ordinary shares subject to possible redemption; 4,646,574 and 30,945,072 shares at a redemption value of $10.46 and $10.14 per share at June 30, 2023 and December 31, 2022, respectively	48,622,587	313,913,217
Shareholders' Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
Additional paid-in capital	0
Accumulated deficit	(17,634,384)	(16,161,254)
Total Shareholders' Deficit	(17,633,610)	(16,160,480)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT	48,699,510	314,188,855
Class A ordinary shares
Current liabilities
Class A ordinary shares subject to possible redemption; 4,646,574 and 30,945,072 shares at a redemption value of $10.46 and $10.14 per share at June 30, 2023 and December 31, 2022, respectively	48,622,587	313,913,217
Shareholders' Deficit
Common stock value	0
Class B ordinary shares
Shareholders' Deficit
Common stock value	$ 774	$ 774

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Preferred stock par value	$ 0.0001	$ 0.0001
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Class A ordinary shares
Ordinary shares subject to possible redemption	4,646,574	30,945,072
Ordinary shares subject to possible redemption par value	$ 10.46	$ 10.14
Common stock par value	$ 0.0001	$ 0.0001
Common stock shares authorized	500,000,000	500,000,000
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Class B ordinary shares
Common stock par value	$ 0.0001	$ 0.0001
Common stock shares authorized	50,000,000	50,000,000
Common stock shares issued	7,736,268	7,736,268
Common stock shares outstanding	7,736,268	7,736,268

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating and formation costs	$ 547,114	$ 243,574	$ 861,523	$ 1,946,336
Loss from operations	(547,114)	(243,574)	(861,523)	(1,946,336)
Other income (expense):
Change in fair value of warrant liabilities	(228,531)	2,594,396	(611,607)	7,097,595
Interest earned on cash and investments held in the Trust Account	519,310	417,862	3,294,864	448,071
Other income, net	290,779	3,012,258	2,683,257	7,545,666
Net (loss) income	(256,335)	2,768,684	1,821,734	5,599,330
Common Class A [Member]
Other income (expense):
Net (loss) income	$ (96,188)	$ 2,214,947	$ 1,214,113	$ 4,479,464
Basic weighted average shares outstanding	4,646,574	30,945,072	15,458,179	30,945,072
Basic net (loss) income per share	$ (0.02)	$ 0.07	$ 0.08	$ 0.14
Diluted weighted average shares outstanding	4,646,574	30,945,072	15,458,179	30,945,072
Diluted net (loss) income per share	$ (0.02)	$ 0.07	$ 0.08	$ 0.14
Common Class B [Member]
Other income (expense):
Net (loss) income	$ (160,147)	$ 553,737	$ 607,621	$ 1,119,866
Basic weighted average shares outstanding	7,736,268	7,736,268	7,736,268	7,736,268
Basic net (loss) income per share	$ (0.02)	$ 0.07	$ 0.08	$ 0.14
Diluted weighted average shares outstanding	7,736,268	7,736,268	7,736,268	7,736,268
Diluted net (loss) income per share	$ (0.02)	$ 0.07	$ 0.08	$ 0.14

Condensed Consolidated Statements of Changes in Shareholders' Deficit - USD ($)	Total	Class B ordinary shares	Common Stock [Member] Class B ordinary shares	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2021	$ (18,904,696)		$ 774	$ 0	$ (18,905,470)
Beginning balance, shares at Dec. 31, 2021			7,736,268
Net (loss) income	2,830,646				2,830,646
Ending balance at Mar. 31, 2022	(16,074,050)		$ 774		(16,074,824)
Ending balance, shares at Mar. 31, 2022			7,736,268
Beginning balance at Dec. 31, 2021	(18,904,696)		$ 774	0	(18,905,470)
Beginning balance, shares at Dec. 31, 2021			7,736,268
Net (loss) income	5,599,330	$ 1,119,866
Ending balance at Jun. 30, 2022	(13,753,437)		$ 774		(13,754,211)
Ending balance, shares at Jun. 30, 2022			7,736,268
Beginning balance at Dec. 31, 2021	(18,904,696)		$ 774	0	(18,905,470)
Beginning balance, shares at Dec. 31, 2021			7,736,268
Ending balance at Dec. 31, 2022	(16,160,480)		$ 774	0	(16,161,254)
Ending balance, shares at Dec. 31, 2022			7,736,268
Beginning balance at Mar. 31, 2022	(16,074,050)		$ 774		(16,074,824)
Beginning balance, shares at Mar. 31, 2022			7,736,268
Accretion for Class A ordinary shares to redemption amount	(448,071)				(448,071)
Net (loss) income	2,768,684	553,737			2,768,684
Ending balance at Jun. 30, 2022	(13,753,437)		$ 774		(13,754,211)
Ending balance, shares at Jun. 30, 2022			7,736,268
Beginning balance at Dec. 31, 2022	(16,160,480)		$ 774	0	(16,161,254)
Beginning balance, shares at Dec. 31, 2022			7,736,268
Shareholder non redemption agreement	(744,274)			(744,274)
Contribution by Sponsor	744,274			744,274
Accretion for Class A ordinary shares to redemption amount	(2,775,554)				(2,775,554)
Net (loss) income	2,078,069				2,078,069
Ending balance at Mar. 31, 2023	(16,857,965)		$ 774		(16,858,739)
Ending balance, shares at Mar. 31, 2023			7,736,268
Beginning balance at Dec. 31, 2022	(16,160,480)		$ 774	0	(16,161,254)
Beginning balance, shares at Dec. 31, 2022			7,736,268
Net (loss) income	1,821,734	607,621
Ending balance at Jun. 30, 2023	(17,633,610)		$ 774		(17,634,384)
Ending balance, shares at Jun. 30, 2023			7,736,268
Beginning balance at Mar. 31, 2023	(16,857,965)		$ 774		(16,858,739)
Beginning balance, shares at Mar. 31, 2023			7,736,268
Accretion for Class A ordinary shares to redemption amount	(519,310)				(519,310)
Net (loss) income	(256,335)	$ (160,147)			(256,335)
Ending balance at Jun. 30, 2023	$ (17,633,610)		$ 774		$ (17,634,384)
Ending balance, shares at Jun. 30, 2023			7,736,268

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net income			$ 1,821,734	$ 5,599,330
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on cash and investments held in Trust Account	$ (519,310)	$ (417,862)	(3,294,864)	(448,071)
Change in fair value of warrant liabilities	228,531	(2,594,396)	611,607	(7,097,595)
Changes in operating assets and liabilities:
Due from Sponsor			(1,500)	(1,500)
Prepaid expenses			17,901	119,464
Accounts payable and accrued expenses			362,808	1,372,543
Net cash used in operating activities			(482,314)	(455,829)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account in connection with redemption			268,585,494	0
Net cash provided by investing activities			268,585,494	0
Cash Flows from Financing Activities:
Related party advance			300,000	0
Redemption of ordinary shares			(268,585,494)	0
Net cash used in financing activities			(268,285,494)	0
Net Change in Cash			(182,314)	(455,829)
Cash – Beginning of the period			212,608	861,474
Cash – End of the period	$ 30,294	$ 405,645	$ 30,294	$ 405,645

Description of Organization and Business Operations	6 Months Ended
Description of Organization and Business Operations	Jun. 30, 2023
Business Description And Basis Of Presentation [Abstract]
Description of Organization and Business Operations	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS DHC Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on December 22, 2020 . The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company has one wholly owned subsidiary that were created on July 22, 2022 , Glory Merger Subsidiary Corp., a Delaware corporation (“Merger Sub”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On March 3, 2023, the Company held an extraordinary general meeting (the “Extension Meeting”) to vote on a number of proposals, including a proposal to approve an amendment the Company’s amended and restated memorandum and articles of association to (i) extend the date by which the Company has to consummate a business combination from March 4, 2023 to December 4, 2023 (the “Combination Period”). The proposal was approved by the Company’s shareholders. In connection with the Extension Meeting, the holders of 26,298,498 Class A ordinary shares of the Company (the “Redeeming Shareholders”) properly exercised their right to redeem their Class A ordinary shares for cash at a redemption price of approximately $10.21 per share, for an aggregate redemption amount of approximately $268,585,000. This could adversely impact the Company’s ability to consummate a business combination within the Combination Period. All activity through June 30, 2023 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the cash held in an interest bearing account), along with income or loss from the change in fair value of the warrant liabilities. The registration statement for the Company’s Initial Public Offering was declared effective on March 1, 2021. On March 4, 2021, the Company consummated the Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300,000,000 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,000,000 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor generating gross proceeds of $9,000,000, which is described in Note 4. Following the closing of the Initial Public Offering on March 4, 2021, an amount of $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule2a-7of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below. On March 5, 2021, the underwriters partially exercised their over-allotment option, resulting in an additional 945,072 Units issued for an aggregate amount of $9,450,720. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 126,010 Private Placement Warrants at $1.50 per Private Placement Warrant, generating total proceeds of $189,015. A total of $9,450,720 was deposited into the Trust Account, bringing the aggregate proceeds deposited in the Trust Account to $309,450,720. Transaction costs amounted to $17,501,346, consisting of $6,189,014 in cash underwriting fees, net of reimbursement, $10,830,775 of deferred underwriting fees and $481,557 of other offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The rules of the stock exchange that the Company will list its securities on will require that the Company’s initial Business Combination must be with one or more target businesses that have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the signing of a definitive agreement in connection with the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company will provide the holders of its issued and outstanding Public Shares (the “Public Shareholders ”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and net of taxes payable), divided by the number of then issued and outstanding Public Shares. The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote any Founder Shares (as defined in Note 5) and Public Shares held by it in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against an Initial Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association will provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors have agreed to waive (i) their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with the completion of the Company’s Business Combination and (ii) their redemption rights with respect to the Founder Shares and any Public Shares held by them in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period or (B) with respect to any other provision relating to shareholders’ rights and (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to consummate an initial business combination within the Combination Period. If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at aper-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per-share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. On July 25, 2022, we entered into a Business Combination Agreement and Plan of Reorganization (the “Business Combination Agreement”), by and among the Company, Glory Merger Subsidiary Corp., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”) and With Purpose, Inc. (d/b/a GloriFi, Inc.) a Delaware corporation (“GloriFi”). On January 26, 2023, we sent GloriFi written notice that we had terminated the Business Combination Agreement, pursuant to Section 9.01(i) and Section 9.01(f) the Business Combination Agreement. Our decision to terminate the Business Combination Agreement took into account the fact that GloriFi had previously publicly announced that GloriFi was winding down its operations and closing its digital banking platform and other products. As a result of the termination of the Business Combination Agreement, each of the Ancillary Agreements (as defined in the Business Combination Agreement) were terminated. Liquidity and Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As of June 30, 2023, the Company had $30,294 in its operating bank account and a working capital deficit of $6,026,818. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of June 30, 2023, there were no amounts outstanding under any Working Capital Loan. In connection with the extraordinary general meeting of shareholders held on March 3, 2023 (the “Extension Meeting”), to extend the date by which the Company has to consummate a business combination (the “Articles Extension”) from March 4, 2023 to December 4, 2023, the Company and the Sponsor, have entered into one or more non-redemption agreements (the “Non-Redemption Agreements”), with several unaffiliated third parties, pursuant to which such third parties agreed not to redeem (or to validly rescind any redemption requests on) an aggregate of 400,000 previously-held Class A ordinary shares of the Company (“Non-Redeemed Shares”) in connection with the Articles Extension. In exchange for the foregoing commitments not to redeem such previously held Class A ordinary shares, the Sponsor agreed to transfer an aggregate of 150,000 Class B ordinary shares of the Company held by the Sponsor to such third parties immediately following consummation of an initial business combination if such third parties continued to hold such Non-Redeemed Shares through the Extension Meeting. In Connection with Extension meeting, the Redeeming Shareholders properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.21 per share, for an aggregate redemption amount of approximately $268,585,000. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 4, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management plans to consummate a business combination prior to the mandatory liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 4, 2023 .

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

10-Q

and Article 8 of Regulation

S-X

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report

on Form

10-K

as filed with

Principles of Consolidation

Emerging Growth Company

non-emerging

Use of Estimates

one or more future confirming events

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of

three months

or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.

Cash and Investments Held in Trust Account

Trust Account Receivable

Concentration of Credit Risk

Offering Costs

17,501,346

, of which $

16,915,008

was charged to temporary shareholders’ deficit upon the completion of the Initial Public Offering and $

586,339

was expensed at the date of the initial public offering.

Class A Ordinary Shares Subject to Possible Redemption

paid-in

capital and accumulated deficit.

At June 30, 2023 and December 31, 2022, the Class A ordinary shares reflected in the unaudited condensed consolidated balance sheets are reconciled in the following table:


Gross proceeds	$	309,450,720
Less:
Proceeds allocated to Public Warrants		(10,211,874	)
Class A ordinary shares issuance costs		(16,924,264	)
Plus:
Accretion of carrying value to redemption value		27,136,138

Class A ordinary shares subject to possible redemption as of December 31, 2021		309,450,720
Plus:
Accretion of carrying value to redemption value		4,462,497

Class A ordinary shares subject to possible redemption as of December 31, 2022		313,913,217
Less:
Redemption		(268,585,494	)
Plus:
Accretion of carrying value to redemption value		3,294,864

Class A ordinary shares subject to possible redemption as of June 30, 2023 (unaudited)	$	48,622,587

Warrant Liabilities

ASC815-40

re-measurement

the

detachment of the Public Warrants from the Units, the Public Warrant quoted market price will be used as the fair value as of each relevant date.

Income Taxes

Net Income (Loss) per Ordinary Share

two-class

16,441,034

shares of Class A ordinary share in the aggregate. As of June 30, 2023 and 2022, the Company did

The following table reflects the calculation of basic and diluted net Income (Loss) per ordinary share (in dollars, except per share amounts):


	For the Three Months Ended June 30,
	2023						2022
	Class A			Class B			Class A		Class B
Basic and diluted net Income (Loss) per ordinary share
Numerator:
Allocation of net Income (Loss), as adjusted	$	(96,188	)	$	(160,147	)	$	2,214,947	$	553,737
Denominator:
Basic and diluted weighted average shares outstanding		4,646,574			7,736,268			30,945,072		7,736,268

Basic and diluted net Income (Loss) per ordinary share	$	(0.02	)	$	(0.02	)	$	0.07	$	0.07


	For the Six Months Ended June 30,
	2023				2022
	Class A		Class B		Class A		Class B
Basic and diluted net income per ordinary share
Numerator:
Allocation of net income, as adjusted	$	1,214,113	$	607,621	$	4,479,464	$	1,119,866
Denominator:
Basic and diluted weighted average shares outstanding		15,458,179		7,736,268		30,945,072		7,736,268

Basic and diluted net income per ordinary share	$	0.08	$	0.08	$	0.14	$	0.14

Fair Value of Financial Instruments

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”)

2020-06,

Debt—Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic

815-40)

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all convertible instruments. As a smaller reporting company, ASU

2020-06

would have on its financial position, results of operations or cash flows. The Company has not adopted this guidance as of June 30, 2023.

Public Offering	6 Months Ended
Public Offering	Jun. 30, 2023
Equity [Abstract]
Public Offering	NOTE 3. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 30,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9). On March 5, 2021, the underwriters partially exercised their over-allotment option, resulting in an additional 945,072 Units issued for an aggregate amount of $9,450,720. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 126,010 Private Placement Warrants at $1.50 per Private Placement Warrant, generating total proceeds of $189,015. A total of $9,450,720 was deposited into the Trust Account, bringing the aggregate proceeds deposited in the Trust Account to $309,450,720.

Private Placement	6 Months Ended
Private Placement	Jun. 30, 2023
Private Placement [Abstract]
Private Placement	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased 6,000,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $9,000,000. The Sponsor agreed to purchase up to an additional 600,000 Private Placement Warrants, for an aggregate purchase price of an additional $900,000, if the over-allotment option is exercised in part by the underwriters. On March 5, the Sponsor purchased 126,010 Private Placement Warrants for an additional aggregate purchase price of $189,015 in connection with the partial exercise of the underwriter’s over-allotment option. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.

Related Party Transactions

6 Months Ended

Jun. 30, 2023

Related Party Transactions

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

30-trading day

Administrative Services Agreement

Promissory Note — Related Party

On December 29, 2020, the Sponsor issued an unsecured promissory

note

to the Company (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was

non-interest

Related Party Advance

consolidated

balance sheets.

Related Party Loans

Non-Redemption

Agreement

On February 28, 2023, the Sponsor entered into

Non-Redemption

Agreements with various stockholders of the

Company

Non-Redeeming

Shareholders to be $744,274 or $4.96 per share. Each

Non-Redeeming

paid-in

capital to recognize the fair value of the shares transferred as an offering cost during the three and six months ended June 30, 2023.

The fair value of the founders shares was based on the following significant inputs:


	February 28, 2023
Risk-free interest rate		4.72	%
Remaining life of SPAC		0.68
Value in no De-SPAC scenario	$	0.00
Probability of transaction		50.00	%

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 6. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or the completion of the Business Combination, the specific impact is not readily determinable as of the date of these unaudited condensed consolidated financial statements. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Various social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide. Specifically, the rising conflict between Russia and Ukraine, and resulting market volatility could adversely affect the Company’s ability to complete a business combination. In response to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a business combination and the value of the Company’s securities. Registration Rights Pursuance to a registration rights agreement entered into on March 4, 2021, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provide that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i) in the case of the Founder Shares, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On March 5, 2021, the underwriters elected to partially exercise their over-allotment option to purchase an additional 945,072 Units and their option to purchase an additional 3,554,928 Units expired. The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,830,775 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Consulting Agreement On January 27, 2021, the Company entered into a Consulting Agreement for financial advisory services. The Company agrees to pay the consultant $2,000,000 and reimburse the consultant for all reasonable and documented expenses, which shall be earned upon announcement of an initial Business Combination and payable at the closing of the initial Business Combination. Business Combination Agreement On July 25, 2022, the Company entered into the Business Combination Agreement, by and among the Company, Merger Sub and GloriFi which was subsequently terminated on January 26, 2023. Business Combination Expense Reimbursement Agreement On February 21, 2022, the Company and GloriFi entered into an agreement pursuant to which GloriFi agreed to reimburse the Company certain business combination related expenses. During the year ended December 31, 2022, the Company wrote off $517,430 as bad debt in relation to this agreement. Termination of Business Combination Agreement On January 26, 2023, the Company sent GloriFi written notice that the Company had terminated the Business Combination Agreement, pursuant to Section 9.01(i) and Section 9.01(f) the Business Combination Agreement. The Company’s decision to terminate the Business Combination Agreement took into account the fact that GloriFi publicly announced that GloriFi was winding down its operations and closing its digital banking platform and other products. As a result of the termination of the Business Combination Agreement, each of the Ancillary Agreements (as defined in the Business Combination Agreement) were terminated.

Shareholders' Deficit	6 Months Ended
Shareholders' Deficit	Jun. 30, 2023
Stockholders' Equity Note [Abstract]
Shareholders' Deficit	NOTE 7. SHAREHOLDERS’ DEFICIT Preference Shares — The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At June 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding. Class A Ordinary Shares — The Company is authorized to issue 500,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At June 30, 2023 and December 31, 2022, there were 4,646,574 and 30,945,072 shares of Class A ordinary shares subject to possible redemption, respectively, which are presented as temporary equity. Class B Ordinary Shares — The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. At June 30, 2023 and December 31, 2022, there were 7,736,268 shares of Class B ordinary shares issued and outstanding. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law; provided that only holders of Class B ordinary shares have the right to vote on the appointment of directors prior to the Company’s initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 20% of the sum of all ordinary shares issued and outstanding upon completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company).

Warrants Liabilities

6 Months Ended

Jun. 30, 2023

Warrants Liabilities [Abstract]

Warrants Liabilities

NOTE 8. WARRANT LIABILITIES

one year

from the closing of the Initial Public Offering and (b) 30 days after the completion of a Business Combination. The Public Warrants will expire

five years

after the completion of a Business Combination or earlier upon redemption or liquidation.

Once the warrants become exercisable, the Company may redeem the Public Warrants for redemption (Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00):

•

in whole and not in part;

•

at a price of $

0.01

per warrant;

•

upon a minimum of

days’ prior written notice of redemption to each warrant holder; and

•

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $

18.00

per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any

trading days within a

trading days period ending three trading days before the Company sends the notice of redemption to the warrant holders.

the 30-day redemption

Redemption

of warrants when the price per Class

A ordinary share equals or exceeds $10.00.

Once the warrants become exercisable, the Company may redeem the outstanding warrants:

•

in whole and not in part;

•

at $

0.10

per warrant upon a minimum of

days’ prior written notice of redemption

provided

•

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $

10.00

per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any

trading days within the

trading day period ending three trading days before the Company send the notice of redemption to the warrant holders; and

•

if the closing price of the Class A ordinary shares for any

trading days within

-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $

18.00

per share, the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants.

non-redeemable

Fair Value Measurements

6 Months Ended

Jun. 30, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

NOTE 9. FAIR VALUE MEASUREMENTS


Level 1:		Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:		Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:		Unobservable inputs based on an assessment of the assumptions that market participants would use in pricing the asset or liability.


	June 30, 2023				December 31, 2022
	Level		Amount		Level		Amount
Assets:
Cash and investments held in Trust Account		1	$	48,590,022		1	$	313,913,217
Liabilities:
Warrant Liabilities – Public Warrants		2	$	486,869		2	$	103,150
Warrant Liabilities – Private Placement Warrants		2	$	289,148		2	$	61,260

The Warrants were accounted for as liabilities in accordance with ASC

815-40

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the condensed consolidated balance sheets date up to the date that the unaudited condensed consolidated financial statements were available to be issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements.

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

10-Q

and Article 8 of Regulation

S-X

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report

on Form

10-K

as filed with

Principles of Consolidation

Emerging Growth Company

Use of Estimates

one or more future confirming events

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of

three months

or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.

Cash and Investment Held in Trust Account

Cash and Investments Held in Trust Account

Trust Account Receivable

Concentration of Credit Risk

Offering Costs

17,501,346

, of which $

16,915,008

was charged to temporary shareholders’ deficit upon the completion of the Initial Public Offering and $

586,339

was expensed at the date of the initial public offering.

Class A Ordinary Shares Subject to Possible Redemption

paid-in

capital and accumulated deficit.

At June 30, 2023 and December 31, 2022, the Class A ordinary shares reflected in the unaudited condensed consolidated balance sheets are reconciled in the following table:


Gross proceeds	$	309,450,720
Less:
Proceeds allocated to Public Warrants		(10,211,874	)
Class A ordinary shares issuance costs		(16,924,264	)
Plus:
Accretion of carrying value to redemption value		27,136,138

Class A ordinary shares subject to possible redemption as of December 31, 2021		309,450,720
Plus:
Accretion of carrying value to redemption value		4,462,497

Class A ordinary shares subject to possible redemption as of December 31, 2022		313,913,217
Less:
Redemption		(268,585,494	)
Plus:
Accretion of carrying value to redemption value		3,294,864

Class A ordinary shares subject to possible redemption as of June 30, 2023 (unaudited)	$	48,622,587

Warrant Liabilities

ASC815-40

re-measurement

the

detachment of the Public Warrants from the Units, the Public Warrant quoted market price will be used as the fair value as of each relevant date.

Income Taxes

Net Income (Loss) per Ordinary Share

two-class

16,441,034

shares of Class A ordinary share in the aggregate. As of June 30, 2023 and 2022, the Company did

The following table reflects the calculation of basic and diluted net Income (Loss) per ordinary share (in dollars, except per share amounts):


	For the Three Months Ended June 30,
	2023						2022
	Class A			Class B			Class A		Class B
Basic and diluted net Income (Loss) per ordinary share
Numerator:
Allocation of net Income (Loss), as adjusted	$	(96,188	)	$	(160,147	)	$	2,214,947	$	553,737
Denominator:
Basic and diluted weighted average shares outstanding		4,646,574			7,736,268			30,945,072		7,736,268

Basic and diluted net Income (Loss) per ordinary share	$	(0.02	)	$	(0.02	)	$	0.07	$	0.07


	For the Six Months Ended June 30,
	2023				2022
	Class A		Class B		Class A		Class B
Basic and diluted net income per ordinary share
Numerator:
Allocation of net income, as adjusted	$	1,214,113	$	607,621	$	4,479,464	$	1,119,866
Denominator:
Basic and diluted weighted average shares outstanding		15,458,179		7,736,268		30,945,072		7,736,268

Basic and diluted net income per ordinary share	$	0.08	$	0.08	$	0.14	$	0.14

Fair Value of Financial Instruments

Recently Accounting Standards

Recent Accounting Standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”)

2020-06,

Debt—Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic

815-40)

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all convertible instruments. As a smaller reporting company, ASU

2020-06

would have on its financial position, results of operations or cash flows. The Company has not adopted this guidance as of June 30, 2023.

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Accounting Policies [Abstract]

Summary of Basic and Diluted Income (Loss) Per Ordinary Share

The following table reflects the calculation of basic and diluted net Income (Loss) per ordinary share (in dollars, except per share amounts):


	For the Three Months Ended June 30,
	2023						2022
	Class A			Class B			Class A		Class B
Basic and diluted net Income (Loss) per ordinary share
Numerator:
Allocation of net Income (Loss), as adjusted	$	(96,188	)	$	(160,147	)	$	2,214,947	$	553,737
Denominator:
Basic and diluted weighted average shares outstanding		4,646,574			7,736,268			30,945,072		7,736,268

Basic and diluted net Income (Loss) per ordinary share	$	(0.02	)	$	(0.02	)	$	0.07	$	0.07


	For the Six Months Ended June 30,
	2023				2022
	Class A		Class B		Class A		Class B
Basic and diluted net income per ordinary share
Numerator:
Allocation of net income, as adjusted	$	1,214,113	$	607,621	$	4,479,464	$	1,119,866
Denominator:
Basic and diluted weighted average shares outstanding		15,458,179		7,736,268		30,945,072		7,736,268

Basic and diluted net income per ordinary share	$	0.08	$	0.08	$	0.14	$	0.14

Summary of Class A Common Stock Subject to Redemption

At June 30, 2023 and December 31, 2022, the Class A ordinary shares reflected in the unaudited condensed consolidated balance sheets are reconciled in the following table:


Gross proceeds	$	309,450,720
Less:
Proceeds allocated to Public Warrants		(10,211,874	)
Class A ordinary shares issuance costs		(16,924,264	)
Plus:
Accretion of carrying value to redemption value		27,136,138

Class A ordinary shares subject to possible redemption as of December 31, 2021		309,450,720
Plus:
Accretion of carrying value to redemption value		4,462,497

Class A ordinary shares subject to possible redemption as of December 31, 2022		313,913,217
Less:
Redemption		(268,585,494	)
Plus:
Accretion of carrying value to redemption value		3,294,864

Class A ordinary shares subject to possible redemption as of June 30, 2023 (unaudited)	$	48,622,587

Related Party Transactions (Tables)

6 Months Ended

Jun. 30, 2023

Fair Value Measurement Inputs and Valuation Techniques [Abstract]

Schedule Of Fair Value Of Founder Shares

The fair value of the founders shares was based on the following significant inputs:


	February 28, 2023
Risk-free interest rate		4.72	%
Remaining life of SPAC		0.68
Value in no De-SPAC scenario	$	0.00
Probability of transaction		50.00	%

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2023

Fair Value Disclosures [Abstract]

Summary Company's Liabilities that are Measured at Fair Value on a Recurring Basis


	June 30, 2023				December 31, 2022
	Level		Amount		Level		Amount
Assets:
Cash and investments held in Trust Account		1	$	48,590,022		1	$	313,913,217
Liabilities:
Warrant Liabilities – Public Warrants		2	$	486,869		2	$	103,150
Warrant Liabilities – Private Placement Warrants		2	$	289,148		2	$	61,260

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)				3 Months Ended			6 Months Ended	12 Months Ended
	Mar. 03, 2023	Mar. 05, 2021	Mar. 04, 2021	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	Feb. 28, 2023	Mar. 05, 2022
Company, incorporation date							Dec. 22, 2020
Stock issued during period, value			$ 300,000,000
Payment to acquire restricted investments							$ 9,450,720
Transaction cost				$ 17,501,346			17,501,346
Assets held in the trust account				309,450,720			309,450,720
Deferred underwriting fee payable				10,830,775			10,830,775
Other offering costs payable				$ 481,557			$ 481,557
Percentage of asset held in trust account				80.00%			80.00%
Number of days related to payment to acquire restricted investment							2 days
Net tangible assets required for consummation of business combination				$ 5,000,001			$ 5,000,001
Number of days for consummation of business combination							10 days
Dissolution expenses							$ 100,000
Cash underwriting fess Net of reimbursement			6,189,014
Cash				30,294			30,294	$ 212,608
Working capital				6,026,818			6,026,818
Promissory note – related party				300,000			$ 300,000
Temporary Equity Accretion To Redemption Value				$ 519,310	$ 2,775,554	$ 448,071
Definitive Agreement of Initial Business Combination [Member]
Business combination, percentage of voting interest acquired				50.00%			50.00%
Common Stock [Member]
Temporary equity redemption price per share				$ 10			$ 10
Restricted percentage of redemption							15.00%
Percentage of redemption							100.00%
Share price				10			$ 10
Maximum [Member]
U.S. government securities, maturity terms							185 days
Minimum [Member]
U.S. government securities, maturity terms							0 days
Sponsor [Member]
Share price				$ 12			$ 12
Promissory note – related party				$ 300,000			$ 300,000	$ 0
Sponsor [Member] \| Working Capital Loan [Member]
Promissory note – related party				$ 0			$ 0
Glory Merger Subsidiary Corp [Member]
Company, incorporation date							Jul. 22, 2022
Common Class A [Member]
Temporary equity redemption price per share	$ 10.21			$ 0.03			$ 0.03
Common stock shares outstanding				0			0	0
Temporary Equity Accretion To Redemption Value							$ 3,294,864	$ 4,462,497	$ 27,136,138
Common Class A [Member] \| DHC Acquisition Corp [Member]
Temporary equity redemption price per share	$ 10.21
Stock issued during period, stock options exercised	26,298,498
Temporary Equity Accretion To Redemption Value	$ 268,585,000
Common Class A [Member] \| Common Stock [Member]
Temporary Equity Accretion To Redemption Value	$ 268,585,000
Common Class A [Member] \| Private Placement Warrants [Member]
Share price				$ 18			$ 18
Non-Redeemable Common Class A [Member]
Common stock shares outstanding	400,000									400,000
Non-Redeemable Common Class A [Member] \| Sponsor [Member]
Number of shares agreed to transfer	150,000
IPO [Member]
Proceeds from issuance of warrants									$ 10,211,874
Share price				10			$ 10
IPO [Member] \| Private Placement Warrants [Member] \| Sponsor [Member]
Class of warrant or rights issued during period							6,000,000
Class of warrant or rights issued during period, price per warrant or right				$ 1.5			$ 1.5
Proceeds from issuance of warrants							$ 9,000,000
Proceeds from sale of equity			$ 300,000,000
Proceeds from sale of equity, per unit			$ 10
IPO [Member] \| Common Class A [Member]
Stock issued during period shares new issues			30,000,000
Shares issue price			$ 10
Stock issued during period			30,000,000
Over-Allotment Option [Member]
Stock issued during period shares new issues		945,072					4,500,000
Stock issued during period		945,072					4,500,000
Over-Allotment Option [Member] \| Underwriters [Member] \| Partial Exercise Of Over Allotment Option [Member]
Stock issued during period shares new issues		945,072
Stock issued during period, value		$ 9,450,720
Class of warrant or rights issued during period		126,010
Class of warrant or rights issued during period, price per warrant or right		$ 1.5									$ 1.5
Proceeds from issuance of warrants		$ 189,015
Stock issued during period		945,072
Over-Allotment Option [Member] \| Private Placement Warrants [Member] \| Sponsor [Member]
Class of warrant or rights issued during period		126,010
Over-Allotment Option [Member] \| Common Class A [Member]
Stock issued during period shares new issues			30,000,000
Shares issue price			$ 10
Stock issued during period, value		$ 9,450,720
Stock issued during period			30,000,000

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Mar. 03, 2023
Future confirming events	one or more future confirming events
Cash equivalents, Carrying value	$ 0		$ 0
Unrecognized tax benefits	0		0
Unrecognized tax benefits, Amounts accrued for interest and penalties	0		0
Income tax expenses benefit	0		0
FDIC, Insured amount	$ 250,000
Term of short term investments	3 months
Weighted average number diluted shares outstanding adjustment	0	0
Assets Held-in-trust, Noncurrent	$ 48,590,022		313,913,217
Accounts receivable, non current	32,565		887,555
Trust Accounts Receivable [Member]
Accounts receivable	854,990
Cash [Member]
Assets Held-in-trust, Noncurrent	$ 48,590,022
US Treasury Securities [Member]
Assets Held-in-trust, Noncurrent			$ 313,913,217
Class A ordinary shares
Temporary equity shares outstanding	4,646,574		30,945,072
Number of Common stock into which the class of warrant or right be converted	16,441,034
Temproary equity, redemption price per share	$ 0.03			$ 10.21

Summary of Significant Accounting Policies - Summary of Class A Common Stock Subject to Redemption (Detail) - USD ($)	3 Months Ended			6 Months Ended	12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Plus:
Accretion of carrying value to redemption value	$ 519,310	$ 2,775,554	$ 448,071
Class A Ordinary Shares Subject to Possible Redemption	48,622,587			$ 48,622,587	$ 313,913,217
Common Class A [Member]
Less:
Class A ordinary shares issuance costs						$ (16,924,264)
Redemption				(268,585,494)
Plus:
Accretion of carrying value to redemption value				3,294,864	4,462,497	27,136,138
Class A Ordinary Shares Subject to Possible Redemption	$ 48,622,587			$ 48,622,587	$ 313,913,217	309,450,720
IPO [Member]
Temporary Equity [Line Items]
Gross proceeds						309,450,720
Less:
Proceeds allocated to Public Warrants						$ (10,211,874)

Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Ordinary Share (Detail) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Numerator:
Allocation of net Income (Loss) as adjusted	$ (256,335)	$ 2,078,069	$ 2,768,684	$ 2,830,646	$ 1,821,734	$ 5,599,330
Common Class A [Member]
Numerator:
Allocation of net Income (Loss) as adjusted	$ (96,188)		$ 2,214,947		$ 1,214,113	$ 4,479,464
Denominator:
Basic weighted average shares outstanding	4,646,574		30,945,072		15,458,179	30,945,072
Diluted weighted average shares outstanding	4,646,574		30,945,072		15,458,179	30,945,072
Basic net income per ordinary share	$ (0.02)		$ 0.07		$ 0.08	$ 0.14
Diluted net income per ordinary share	$ (0.02)		$ 0.07		$ 0.08	$ 0.14
Common Class B [Member]
Numerator:
Allocation of net Income (Loss) as adjusted	$ (160,147)		$ 553,737		$ 607,621	$ 1,119,866
Denominator:
Basic weighted average shares outstanding	7,736,268		7,736,268		7,736,268	7,736,268
Diluted weighted average shares outstanding	7,736,268		7,736,268		7,736,268	7,736,268
Basic net income per ordinary share	$ (0.02)		$ 0.07		$ 0.08	$ 0.14
Diluted net income per ordinary share	$ (0.02)		$ 0.07		$ 0.08	$ 0.14

Public Offering - Additional Information (Detail) - USD ($)			6 Months Ended	12 Months Ended
	Mar. 05, 2021	Mar. 04, 2021	Jun. 30, 2023	Dec. 31, 2021	Mar. 05, 2022
Public Offering [Line Items]
Stock issued during period value new issues		$ 300,000,000
Payment to acquire restricted investments			$ 9,450,720
Assets held in the trust account			$ 309,450,720
IPO [Member]
Public Offering [Line Items]
Proceeds from sale of Private Placement Warrants				$ 10,211,874
Over-Allotment Option [Member]
Public Offering [Line Items]
Stock issued during period shares new issues	945,072		4,500,000
Over-Allotment Option [Member] \| Partial Exercise Of Over Allotment Option [Member] \| Underwriters [Member]
Public Offering [Line Items]
Stock issued during period shares new issues	945,072
Stock issued during period value new issues	$ 9,450,720
Class of warrant or rights issued during period	126,010
Class of warrant or rights issued during period, price per warrant or right	$ 1.5				$ 1.5
Proceeds from sale of Private Placement Warrants	$ 189,015
Common Class A [Member] \| Public Warrants [Member]
Public Offering [Line Items]
Common stock, conversion basis		Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9).
Common Class A [Member] \| IPO [Member]
Public Offering [Line Items]
Stock issued during period shares new issues		30,000,000
Shares issue price		$ 10
Warrants exercise price per share		$ 11.5
Common Class A [Member] \| Over-Allotment Option [Member]
Public Offering [Line Items]
Stock issued during period shares new issues		30,000,000
Shares issue price		$ 10
Stock issued during period value new issues	$ 9,450,720

Private Placement - Additional Information (Detail) - USD ($)		6 Months Ended	12 Months Ended
	Mar. 05, 2021	Jun. 30, 2023	Dec. 31, 2021
Private Placement Warrants [Member]
Class of warrants or rights, number of securities called by each warrant or rights		1
Class of warrants or rights, exercise price		$ 11.5
IPO [Member]
Proceeds from issuance of warrants			$ 10,211,874
IPO [Member] \| Sponsor [Member] \| Private Placement Warrants [Member]
Class of warrant or rights issued during period		6,000,000
Class of warrant or rights issued during period, price per warrant or right		$ 1.5
Proceeds from issuance of warrants		$ 9,000,000
Over-Allotment Option [Member] \| Sponsor [Member] \| Private Placement Warrants [Member]
Class of warrant or rights issued during period	126,010
Class of warrants or rights subscribed but not issued		600,000
Class of warrants or rights subscribed but not issued value		$ 900,000
Proceeds from derivative instrument, financing activities	$ 189,015

Related Party Transactions - Schedule Of Fair Value Of Founder Shares (Detail) - Founder Shares [Member]	Feb. 28, 2023 $ / shares yr
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Founder shares measurement input	4.72
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Founder shares measurement input \| yr	0.68
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Founder shares measurement input \| $ / shares	0
Measurement Input Probability Of Transaction [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Founder shares measurement input	50

Related Party Transactions - Additional Information (Detail) - USD ($)						1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 18, 2023	Mar. 03, 2023	Feb. 28, 2023	Mar. 04, 2021	Mar. 01, 2021	Dec. 31, 2020	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 29, 2020
Related Party Transaction [Line Items]
Related party advances							$ 300,000		$ 300,000
Sponsor [Member]
Related Party Transaction [Line Items]
Share price							$ 12		$ 12
Notice period to redeem shares									150 days
Related party advances							$ 300,000		$ 300,000		$ 0
Proceeds from advances to related parties	$ 250,000	$ 50,000
Sponsor [Member] \| Working Capital Loan [Member]
Related Party Transaction [Line Items]
Related party advances							0		0
Debt instrument convertible into warrants							$ 1,500,000		$ 1,500,000
Debt instrument conversion price							$ 1.5		$ 1.5
Sponsor [Member] \| Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount												$ 300,000
Related party advances												$ 171,357
Sponsor [Member] \| Administrative Service Agreement [Member]
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction									$ 10,000
Related party transaction. administrative expense							$ 30,000	$ 30,000	60,000	$ 60,000
Sponsor [Member] \| Administrative Service Agreement [Member] \| Accrued Liabilities [Member]
Related Party Transaction [Line Items]
Related party transaction. administrative expense									$ 60,000		$ 120,000
Sponsor [Member] \| Maximum [Member]
Related Party Transaction [Line Items]
Share transfer restriction, threshold trading days									30 days
Sponsor [Member] \| Minimum [Member]
Related Party Transaction [Line Items]
Number of consecutive trading days for share price determination									20 days
Class B ordinary shares
Related Party Transaction [Line Items]
Common stock shares outstanding						8,625,000	7,736,268		7,736,268		7,736,268
Class B ordinary shares \| Founder Shares [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period, value, issued for services						$ 25,000
Stock issued during period, shares, issued for services						7,187,500
Stock issued during period					1,437,500
Ordinary shares subject to possible redemption							1,125,000		1,125,000
Percentage of shares issued and outstanding							20.00%		20.00%
Shares issued, shares, share-based payment arrangement, forfeited				888,732
Non-Redeemable Common Class A [Member]
Related Party Transaction [Line Items]
Common stock shares outstanding		400,000	400,000
Non-Redeemable Common Class A [Member] \| Sponsor Agreement [Member]
Related Party Transaction [Line Items]
Number of shares to be transferred amongst the related parties interest upon consummation of business combination			150,000
Non-Redeemable Common Class A [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Number of shares to be transferred amongst the related parties interest upon consummation of business combination		150,000
Non-Redeemable Common Class A [Member] \| Founder Shares [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Percentage of identified shares			9.90%
Estimated fair value of non-redeeming shares			150,000
Estimated fair value of non-redeeming shares, value			$ 744,274
Estimated fair value of non-redeeming shares, per share			$ 4.96

Commitments and Contingencies - Additional Information (Detail) - USD ($)		6 Months Ended	12 Months Ended
	Mar. 05, 2021	Jun. 30, 2023	Dec. 31, 2022	Jan. 27, 2021
Number of days after the completion of the business combination		30 days
Deferred underwriting fee payable, per unit		$ 0.35
Deferred underwriting fee payable		$ 10,830,775
Stock repurchased and retired during period, shares	3,554,928
Consulting Agreement [Member]
Consultant Fee				$ 2,000,000
Business Combination Expense Reimbursement Agreement [Member]
Bad debt written off			$ 517,430
Over-Allotment Option [Member]
Option vesting period		45 days
Stock issued during period	945,072	4,500,000

Shareholders' Deficit - Additional Information (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2020
Class of Stock [Line Items]
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock par value	$ 0.0001	$ 0.0001
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Stock [Member]
Class of Stock [Line Items]
Percentage of sum of ordinary shares issued and outstanding	20.00%
Common Class A [Member]
Class of Stock [Line Items]
Common stock shares authorized	500,000,000	500,000,000
Common stock par value	$ 0.0001	$ 0.0001
Common stock, voting rights	one
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Temporary equity shares outstanding	4,646,574	30,945,072
Common Class B [Member]
Class of Stock [Line Items]
Common stock shares authorized	50,000,000	50,000,000
Common stock par value	$ 0.0001	$ 0.0001
Common stock, voting rights	one
Common stock shares issued	7,736,268	7,736,268
Common stock shares outstanding	7,736,268	7,736,268	8,625,000
Common stock, conversion basis	one-for-one basis

Warrant Liabilities - Additional Information (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Number of days after consummation of business combination within which registration shall be made with securities exchange commission	20 days
Number of days after consummation of business combination within which registration with securities exchange commission shall be effective	60 days
Common Stock [Member]
Share price	$ 10
Common Class A [Member]
Common stock shares lock in period	30 days
Common Class A [Member] \| Event Triggering Adjustment To Exercise Price Of Warrants [Member]
Proceeds to be used for business combination as a percentage of total equity proceeds	60.00%
Sale of stock issue price per share	$ 9.2
Number of trading days for determining volume weighted average trading price of the ordinary shares	20 days
Volume Weighted Average Trading Price Of Shares	$ 9.2
Common Class A [Member] \| Event Triggering Adjustment To Exercise Price Of Warrants [Member] \| Warrant Exercise Price One [Member]
Class of warrants or rights, Exercise price as a percentage of newly issued price	115.00%
Common Class A [Member] \| Event Triggering Adjustment To Exercise Price Of Warrants [Member] \| Warrant Exercise Price Two [Member]
Class of warrants or rights, Exercise price as a percentage of newly issued price	180.00%
Share Price $10 [Member] \| Common Class A [Member] \| Share Redemption Triger Price [Member]
Share price	$ 10
Public Warrants [Member]
Class of warrants or rights, outstanding	10,315,024	10,315,024
Class of warrants or rights period after which the warrants or rights are exercisable	1 year
Class of warrant or right days from which warrants or rights exercisable	30 days
Warrants or rights outstanding, term	5 years
Public Warrants [Member] \| Common Stock [Member] \| Redemption Trigger Price One [Member]
Share price	$ 18
Public Warrants [Member] \| Common Class A [Member] \| Redemption Trigger Price One [Member]
Share price	18
Class of warrants or rights, redemption price per warrant or right	$ 0.01
Class of warrants or rights, notice of redemption period	30 days
Number of trading days determining closing price of ordinary shares	20 days
Number of consecutive trading days for determining the closing price of shares	30 days
Period during which the registered propsectus shall be available for warrant redemption	30 days
Public Warrants [Member] \| Common Class A [Member] \| Redemption Trigger Price Two [Member]
Share price	$ 10
Class of warrants or rights, redemption price per warrant or right	$ 0.1
Class of warrants or rights, notice of redemption period	30 days
Number of consecutive trading days for determining the closing price of shares	30 days
Private Placement Warrants [Member]
Class of warrants or rights, outstanding	6,126,010	6,126,010
Class of warrants or rights lock in period	30 days
Private Placement Warrants [Member] \| Common Class A [Member]
Share price	$ 18
Number of trading days determining closing price of ordinary shares	20 days
Number of consecutive trading days for determining the closing price of shares	30 days

Fair Value Measurements - Summary Company's Liabilities that are Measured at Fair Value on a Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Level 1 [Member]
Assets:
Cash and investments held in Trust Account	$ 48,590,022	$ 313,913,217
Public Warrants [Member] \| Level 2 [Member] \| Warrant [Member]
Liabilities:
Warrant Liability	486,869	103,150
Private Placement Warrants [Member] \| Level 2 [Member] \| Warrant [Member]
Liabilities:
Warrant Liability	$ 289,148	$ 61,260

Fair Value Measurements - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2022	Jun. 30, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets held in the trust account	$ 313,913,217	$ 48,590,022
Cash [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets held in the trust account		$ 48,590,022
Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers From Level1 To Level3	$ 1,031,502

DHC Acquisition (NASDAQ:DHCAU)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024

Plus de graphiques de la Bourse DHC Acquisition

DHC Acquisition (NASDAQ:DHCAU)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024

Large accelerated filer

Accelerated filer

Non-accelerated
filer

Smaller reporting company

Emerging growth company